The DOI matches its Crossref record; 91 of the 91 references it cites were found in a registry or an index.
Immunopathogenesis of Behcet's Disease
Open accessAbstract
Behcet's disease (BD) is a chronic systemic inflammatory vasculitis of unknown etiology characterized by recurrent episodes of oral aphthous ulcers, genital ulcers, skin lesions, ocular lesions, and other manifestations. Although the pathogenesis of BD is unclear, some studies have shown that immunological aberrations play an important role in the development and progression of BD. Infection-related trigger factors, including antigens and autoantigens, are believed to mediate the development of BD in patients with a genetic predisposition and subsequently activate the innate and adaptive immune systems, resulting in the production of numerous cytokines and chemokines to combat the infection-related factors. The study of the immunological mechanism of BD paves the way for the development of innovative therapies. Recently, novel biotherapy approaches, including interferon-α (IFN-α), tumor necrosis factor-α (TNF-α) antagonists, and other agents that target interleukins and their receptors, have shown promising results in the treatment of patients with refractory BD and have improved the prognosis of BD. In this review, we provide the current concepts of BD immunopathogenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Korn, T., Bettelli, E., Oukka, M., & Kuchroo, V. K. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132710 · Cited by 4,873
IL-23 drives a pathogenic T cell population that induces autoimmune inflammation
Langrish, C. L., Chen, Y., Blumenschein, W. M., Mattson, J., Basham, B., Sedgwick, J. D., McClanahan, T., Kastelein, R. A., & Cua, D. J. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041257 · Cited by 4,099 · cited 2×
“Recent studies have also shown that IL23 does not promote the development of IFN-γ -producing Th1 cells but is one of the essential factors in increasing a pathogenic CD4+ T cell population, which is characterized by the production of IL-17, IL-6, and TNF-α (56).”
BackgroundThe regulation of IL-10 production by immune cells
Saraiva, M., & O'Garra, A. (2010) · Nature Reviews Immunology · doi:10.1038/nri2711 · Cited by 3,164
Neutrophils and immunity: challenges and opportunities
Nathan, C. (2006) · Nature reviews. Immunology · doi:10.1038/nri1785 · Cited by 2,971
Zhou, L., Ivanov, I. I., Spolski, R., Min, R., Shenderov, K., Egawa, T., Levy, D. E., Leonard, W. J., & Littman, D. R. (2007) · Nature Immunology · doi:10.1038/ni1488 · Cited by 2,141
TNF-mediated inflammatory disease
Bradley, Jr. (2008) · The Journal of Pathology · doi:10.1002/path.2287 · Cited by 2,094
TGF-β-induced Foxp3 inhibits TH17 cell differentiation by antagonizing RORγt function
Zhou, L., Lopes, J. E., Chong, M. M. W., Ivanov, I. I., Min, R., Victora, G. D., Shen, Y., Du, J., Rubtsov, Y. P., Rudensky, A. Y., et al. (2008) · Nature · doi:10.1038/nature06878 · Cited by 1,863
Sutton, C. E., Lalor, S. J., Sweeney, C. M., Brereton, C. F., Lavelle, E. C., & Mills, K. H. G. (2009) · Immunity · doi:10.1016/j.immuni.2009.08.001 · Cited by 1,553
Human natural killer cells: a unique innate immunoregulatory role for the CD56bright subset
Cooper, M. A., Fehniger, T. A., Turner, S. C., Chen, K. S., Ghaheri, B. A., Ghayur, T., Carson, W. E., & Caligiuri, M. A. (2001) · Blood · doi:10.1182/blood.v97.10.3146 · Cited by 1,449
Production of interleukin 22 but not interleukin 17 by a subset of human skin-homing memory T cells
Duhen, T., Geiger, R., Jarrossay, D., Lanzavecchia, A., & Sallusto, F. (2009) · Nature Immunology · doi:10.1038/ni.1767 · Cited by 1,079 · cited 2×
“Sugita et al. showed that Th22-type T cell clones could be established from ocular samples obtained from patients with active BD, these clones produced numerous Th22-associated cytokines and overexpressed IL-22, TNF-α, and CCR10.”
BackgroundTh17 and regulatory T cell balance in autoimmune and inflammatory diseases
Noack, M., & Miossec, P. (2014) · Autoimmunity Reviews · doi:10.1016/j.autrev.2013.12.004 · Cited by 932
IL-21 and TGF-β are required for differentiation of human TH17 cells
Yang, L., Anderson, D. E., Baecher-Allan, C., Hastings, W. D., Bettelli, E., Oukka, M., Kuchroo, V. K., & Hafler, D. A. (2008) · Nature · doi:10.1038/nature07021 · Cited by 927
Akdis, M., Aab, A., Altunbulakli, C., Azkur, K., Costa, R. A., Crameri, R., Duan, S., Eiwegger, T., Eljaszewicz, A., Ferstl, R., et al. (2016) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2016.06.033 · Cited by 912
TH17 cells contribute to uveitis and scleritis and are expanded by IL-2 and inhibited by IL-27/STAT1
Amadi-Obi, A., Yu, C.-R., Liu, X., Mahdi, R. M., Clarke, G. L., Nussenblatt, R. B., Gery, I., Lee, Y. S., & Egwuagu, C. E. (2007) · Nature Medicine · doi:10.1038/nm1585 · Cited by 865
Self-citationIL-37 is a fundamental inhibitor of innate immunity
Nold, M. F., Nold-Petry, C. A., Zepp, J. A., Palmer, B. E., Bufler, P., & Dinarello, C. A. (2010) · Nature Immunology · doi:10.1038/ni.1944 · Cited by 849
Phenotypical and functional specialization of FOXP3+ regulatory T cells
Campbell, D. J., & Koch, M. A. (2011) · Nature Reviews Immunology · doi:10.1038/nri2916 · Cited by 773
Synergy of IL-21 and IL-15 in regulating CD8+ T cell expansion and function
Zeng, R., Spolski, R., Finkelstein, S. E., Oh, S., Kovanen, P. E., Hinrichs, C. S., Pise-Masison, C. A., Radonovich, M. F., Brady, J. N., Restifo, N. P., et al. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041057 · Cited by 727
Remmers, E. F., Cosan, F., Kirino, Y., Ombrello, M. J., Abaci, N., Satorius, C., Le, J. M., Yang, B., Korman, B. D., Cakiris, A., et al. (2010) · Nature Genetics · doi:10.1038/ng.625 · Cited by 681
Ozaki, K., Spolski, R., Ettinger, R., Kim, H.-P., Wang, G., Qi, C.-F., Hwu, P., Shaffer, D. J., Akilesh, S., Roopenian, D. C., et al. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.9.5361 · Cited by 668
γδ T Cells: First Line of Defense and Beyond
Chien, Y.-H., Meyer, C., & Bonneville, M. (2014) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032713-120216 · Cited by 636
Fitzgerald, D. C., Zhang, G.-X., El-Behi, M., Fonseca-Kelly, Z., Li, H., Yu, S., Saris, C. J. M., Gran, B., Ciric, B., & Rostami, A. (2007) · Nature Immunology · doi:10.1038/ni1540 · Cited by 529
IL-21 Limits NK Cell Responses and Promotes Antigen-Specific T Cell Activation
Kasaian, M. T., Whitters, M. J., Carter, L. L., Lowe, L. D., Jussif, J. M., Deng, B., Johnson, K. A., Witek, J. S., Senices, M., Konz, R. F., et al. (2002) · Immunity · doi:10.1016/s1074-7613(02)00295-9 · Cited by 481
de Menthon, M., LaValley, M. P., Maldini, C., Guillevin, L., & Mahr, A. (2009) · Arthritis Care & Research · doi:10.1002/art.24642 · Cited by 462
NK cells at the interface between innate and adaptive immunity
Moretta, A., Marcenaro, E., Parolini, S., Ferlazzo, G., & Moretta, L. (2008) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4402170 · Cited by 387
Upregulated IL-23 and IL-17 in Behçet Patients with Active Uveitis
Chi, W., Zhu, X., Yang, P., Liu, X., Lin, X., Zhou, H., Huang, X., & Kijlstra, A. (2008) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.07-1390 · Cited by 321
Self-citationBehçet's disease – a contemporary review
Mendes, D., Correia, M., Barbedo, M., Vaio, T., Mota, M., Gonçalves, O., & Valente, J. (2009) · Journal of Autoimmunity · doi:10.1016/j.jaut.2009.02.011 · Cited by 320
New insights into the pathogenesis of Behçet's disease
Pineton de Chambrun, M., Wechsler, B., Geri, G., Cacoub, P., & Saadoun, D. (2012) · Autoimmunity Reviews · doi:10.1016/j.autrev.2011.11.026 · Cited by 309
Anti-TNF therapy in the management of Behcet's disease--review and basis for recommendations
Sfikakis, P. P., Markomichelakis, N., Alpsoy, E., Assaad-Khalil, S., Bodaghi, B., Gul, A., Ohno, S., Pipitone, N., Schirmer, M., Stanford, M., et al. (2007) · Rheumatology · doi:10.1093/rheumatology/kem034 · Cited by 301
Suppression of inflammation and acquired immunity by IL‐37
Cavalli, G., & Dinarello, C. A. (2018) · Immunological Reviews · doi:10.1111/imr.12605 · Cited by 291
FOXP3+ regulatory T cells and their functional regulation
Li, Z., Li, D., Tsun, A., & Li, B. (2015) · Cellular & Molecular Immunology · doi:10.1038/cmi.2015.10 · Cited by 290
Th17 cells in inflammation and autoimmunity
Singh, R. P., Hasan, S., Sharma, S., Nagra, S., Yamaguchi, D. T., Wong, D. T. W., Hahn, B. H., & Hossain, A. (2014) · Autoimmunity Reviews · doi:10.1016/j.autrev.2014.08.019 · Cited by 266
Leung, S., Liu, X., Fang, L., Chen, X., Guo, T., & Zhang, J. (2010) · Cellular & Molecular Immunology · doi:10.1038/cmi.2010.22 · Cited by 251
Self-citationSawant, D. V., & Vignali, D. A. A. (2014) · Immunological Reviews · doi:10.1111/imr.12173 · Cited by 245
Interleukin-21 inhibits dendritic cell activation and maturation
Brandt, K., Bulfone-Paus, S., Foster, D. C., & Rückert, R. (2003) · Blood · doi:10.1182/blood-2003-03-0669 · Cited by 245
Apremilast for Behçet’s Syndrome — A Phase 2, Placebo-Controlled Study
Hatemi, G., Melikoglu, M., Tunc, R., Korkmaz, C., Turgut Ozturk, B., Mat, C., Merkel, P. A., Calamia, K. T., Liu, Z., Pineda, L., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1408684 · Cited by 244
Critical role of IL-21 in modulating TH17 and regulatory T cells in Behçet disease
Geri, G., Terrier, B., Rosenzwajg, M., Wechsler, B., Touzot, M., Seilhean, D., Tran, T.-A., Bodaghi, B., Musset, L., Soumelis, V., et al. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2011.05.029 · Cited by 226
Vallet, H., Riviere, S., Sanna, A., Deroux, A., Moulis, G., Addimanda, O., Salvarani, C., Lambert, M., Bielefeld, P., Seve, P., et al. (2015) · Journal of Autoimmunity · doi:10.1016/j.jaut.2015.06.005 · Cited by 222
The role of cytokines in the pathogenesis of inflammatory eye disease
WAKEFIELD, D. (1992) · Cytokine · doi:10.1016/1043-4666(92)90028-p · Cited by 217
The immunogenetics of Behçet's disease: A comprehensive review
Takeuchi, M., Kastner, D. L., & Remmers, E. F. (2015) · Journal of Autoimmunity · doi:10.1016/j.jaut.2015.08.013 · Cited by 201
Roles of IL-8 in Ocular Inflammations: A Review
Ghasemi, H., Ghazanfari, T., Yaraee, R., Faghihzadeh, S., & Hassan, Z. M. (2011) · Ocular Immunology and Inflammation · doi:10.3109/09273948.2011.618902 · Cited by 195
Cytokines in Autoimmune Uveitis
Horai, R., & Caspi, R. R. (2011) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2011.0042 · Cited by 178
Neutrophil Activation Promotes Fibrinogen Oxidation and Thrombus Formation in Behçet Disease
Becatti, M., Emmi, G., Silvestri, E., Bruschi, G., Ciucciarelli, L., Squatrito, D., Vaglio, A., Taddei, N., Abbate, R., Emmi, L., et al. (2016) · Circulation · doi:10.1161/circulationaha.115.017738 · Cited by 166
Intraocular Cytokine Environment in Active Behçet Uveitis
Ahn, J. K., Yu, H. G., Chung, H., & Park, Y. G. (2006) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2006.04.016 · Cited by 146
Natural killer cells and autoimmunity
French, A. R., & Yokoyama, W. (2003) · Arthritis Research & Therapy · doi:10.1186/ar1034 · Cited by 144
El‐Asrar, A. M. A., Struyf, S., Kangave, D., Al‐Obeidan, S. A., Opdenakker, G., Geboes, K. J., & Damme, J. V. (2011) · Clinical Immunology · doi:10.1016/j.clim.2011.01.014 · Cited by 141
Interleukin 27: a double-edged sword for offense and defense
Yoshida, H., Nakaya, M., & Miyazaki, Y. (2009) · Journal of Leukocyte Biology · doi:10.1189/jlb.0609445 · Cited by 136
Yamada, Y., Sugita, S., Tanaka, H., Kamoi, K., Kawaguchi, T., & Mochizuki, M. (2009) · British Journal of Ophthalmology · doi:10.1136/bjo.2009.158840 · Cited by 124
Interleukin-22: A likely target for treatment of autoimmune diseases
Yang, X., & Zheng, S. G. (2014) · Autoimmunity Reviews · doi:10.1016/j.autrev.2013.11.008 · Cited by 123
T Cell-Regulated Neutrophilic Inflammation in Autoinflammatory Diseases
Keller, M., Spanou, Z., Schaerli, P., Britschgi, M., Yawalkar, N., Seitz, M., Villiger, P. M., & Pichler, W. J. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.11.7678 · Cited by 122
Th22 in inflammatory and autoimmune disease: prospects for therapeutic intervention
Zhang, N., Pan, H., & Ye, D. (2011) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-011-0772-y · Cited by 120
Regulatory NK cells in autoimmune disease
Tian, Z., Gershwin, M. E., & Zhang, C. (2012) · Journal of Autoimmunity · doi:10.1016/j.jaut.2012.05.006 · Cited by 119
IL-35 and Autoimmunity: a Comprehensive Perspective
Choi, J., Leung, P. S. C., Bowlus, C. L., & Gershwin, M. E. (2015) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-015-8468-9 · Cited by 111
Interleukin 35: Critical regulator of immunity and lymphocyte-mediated diseases
Egwuagu, C. E., Yu, C., Sun, L., & Wang, R. (2015) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2015.07.013 · Cited by 105
Emerging role of IL-35 in inflammatory autoimmune diseases
Su, L., Liu, X., Huang, A., & Xu, W. (2018) · Autoimmunity Reviews · doi:10.1016/j.autrev.2018.01.017 · Cited by 102
Self-citationGül, A., & Ohno, S. (2011) · Ocular Immunology and Inflammation · doi:10.3109/09273948.2011.634978 · Cited by 98
IL-23R gene confers susceptibility to Behcet's disease in a Chinese Han population
Jiang, Z., Yang, P., Hou, S., Du, L., Xie, L., Zhou, H., & Kijlstra, A. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2009.119420 · Cited by 97
Expression of Th-17 and RORgammat mRNA in Behçet’s Disease
Hamzaoui, K., Bouali, E., Ghorbel, I. B., Khanfir, M. S., Houman, H., & Hamzaoui, A. (2011) · Medical Science Monitor · doi:10.12659/msm.881720 · Cited by 97
Biological effects of interleukin-6: Clinical applications in autoimmune diseases and cancers
Ho, L., Luo, S., & Lai, J. (2015) · Biochemical Pharmacology · doi:10.1016/j.bcp.2015.06.009 · Cited by 94
Increased advanced oxidation protein products in Behcet's disease: a new activity marker?
Yazıcı, C., Köse, K., Çalış, M., Demir, M., Kırnap, M., & AteS, F. (2004) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2004.06003.x · Cited by 94
Lee, Y. S., Amadi‐Obi, A., Yu, C., & Egwuagu, C. E. (2011) · Immunology · doi:10.1111/j.1365-2567.2010.03379.x · Cited by 93
RORC and Foxp3 axis in cerebrospinal fluid of patients with Neuro-Behçet's Disease
Hamzaoui, K., Borhani‐Haghighi, A., Ghorbel, I. B., & Houman, H. (2011) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2011.01.012 · Cited by 92
Insights into IL-37, the role in autoimmune diseases
Xu, W., Zhao, Y., & Liu, Y. (2015) · Autoimmunity Reviews · doi:10.1016/j.autrev.2015.08.006 · Cited by 90
Biotherapies in inflammatory ocular disorders: Interferons, immunoglobulins, monoclonal antibodies
Saadoun, D., Bodaghi, B., Bienvenu, B., Wechsler, B., Sène, D., Trad, S., Abad, S., Cacoub, P., Kodjikian, L., & Sève, P. (2013) · Autoimmunity Reviews · doi:10.1016/j.autrev.2013.02.002 · Cited by 90
Intestinal Behçet and Crohn’s disease: two sides of the same coin
Valenti, S., Gallizzi, R., Vivo, D. D., & Romano, C. (2017) · Pediatric Rheumatology · doi:10.1186/s12969-017-0162-4 · Cited by 88
Role of IL-22– and TNF-α–Producing Th22 Cells in Uveitis Patients with Behçet’s Disease
Sugita, S., Kawazoe, Y., Imai, A., Kawaguchi, T., Horie, S., Keino, H., Takahashi, M., & Mochizuki, M. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1202677 · Cited by 81
Roles of IL-10 in Ocular Inflammations: A Review
Ghasemi, H., Ghazanfari, T., Yaraee, R., Owlia, P., Hassan, Z. M., & Faghihzadeh, S. (2012) · Ocular Immunology and Inflammation · doi:10.3109/09273948.2012.723109 · Cited by 74
Efficacy of Infliximab in Intestinal Behçet’s Disease
Lee, J. H., Cheon, J. H., Jeon, S. W., Ye, B. D., Yang, S., Kim, Y. H., Lee, K., Im, J. P., Kim, J. S., Lee, C. K., et al. (2013) · Inflammatory Bowel Diseases · doi:10.1097/mib.0b013e31828f19c9 · Cited by 73
EXPERIMENTAL AUTOIMMUNE UVEITIDES: MULTIPLE ANTIGENS, DIVERSE DISEASES
Adamus, G., & Chan, C. (2002) · International Reviews of Immunology · doi:10.1080/08830180212068 · Cited by 70
IFN-α induces IL-10 production and tilt the balance between Th1 and Th17 in Behçet disease
Touzot, M., Cacoub, P., Bodaghi, B., Soumelis, V., & Saadoun, D. (2014) · Autoimmunity Reviews · doi:10.1016/j.autrev.2014.12.009 · Cited by 69
Natural killer cells control a T-helper 1 response in patients with Behçet's disease
Yamaguchi, Y., Takahashi, H., Satoh, T., Okazaki, Y., Mizuki, N., Takahashi, K., Ikezawa, Z., & Kuwana, M. (2010) · Arthritis Research & Therapy · doi:10.1186/ar3005 · Cited by 68
Regulatory T cells turn pathogenic
Guo, J., & Zhou, X. (2015) · Cellular and Molecular Immunology · doi:10.1038/cmi.2015.12 · Cited by 63
The Role of Th17 Cells in the Pathogenesis of Behcet’s Disease
Nanke, Y., Yago, T., & Kotake, S. (2017) · Journal of Clinical Medicine · doi:10.3390/jcm6070074 · Cited by 62
Activated γδ T Cells Promote the Activation of Uveitogenic T Cells and Exacerbate EAU Development
Nian, H., Shao, H., O’Brien, R. L., Born, W. K., Kaplan, H. J., & Sun, D. (2011) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.10-6758 · Cited by 59
Verjans, G. M. G. M., van Hagen, P. M., van der Kooi, A., Osterhaus, A. D. M. E., & Baarsma, G. S. (2002) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(02)00208-4 · Cited by 55
Key role for IL-21 in experimental autoimmune uveitis
Wang, L., Yu, C., Kim, H., Liao, W., Telford, W. G., Egwuagu, C. E., & Leonard, W. J. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1018182108 · Cited by 55
Lafont, V., Liautard, J., Sablé-teychené, M., Sainte–Marie, Y., & Favero, J. J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008684200 · Cited by 55
Monocytes and γδ T cells: close encounters in microbial infection
Eberl, M., & Moser, B. (2009) · Trends in Immunology · doi:10.1016/j.it.2009.09.001 · Cited by 52
Polymorphisms of interleukin 6 and interleukin 10 in Egyptian people with Behcet's disease
Talaat, R. M., Ashour, M. E., Bassyouni, I. H., & Raouf, A. A. (2014) · Immunobiology · doi:10.1016/j.imbio.2014.03.004 · Cited by 50
Alpha tropomyosin as a self-antigen in patients with Behçet's disease
Mahesh, S. P., Li, Z., Buggage, R. R., Mor, F., Cohen, I. R., Chew, E. Y., & Nussenblatt, R. B. (2005) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2005.02760.x · Cited by 48
Immunopathogenesis of Ocular Behçet’s Disease
Park, U. C., Kim, T., & Yu, H. G. (2014) · Journal of Immunology Research · doi:10.1155/2014/653539 · Cited by 47
Higher Expression of Toll-like Receptors 2, 3, 4, and 8 in Ocular Behcet's Disease
Liu, X., Wang, C., Ye, Z., Kijlstra, A., & Yang, P. (2013) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.13-12159 · Cited by 46
Self-citationIFN- blocks IL-17 production by peripheral blood mononuclear cells in Behcet's disease
Liu, X., Yang, P., Wang, C., Li, F., & Kijlstra, A. (2010) · Rheumatology · doi:10.1093/rheumatology/keq330 · Cited by 43
Self-citationNew therapeutic solutions for Behçet’s syndrome
Vitale, A., Rigante, D., Lopalco, G., Emmi, G., Bianco, M. T., Galeazzi, M., Iannone, F., & Cantarini, L. (2016) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2016.1181751 · Cited by 42
Increased Expression of IL-22 Is Associated with Disease Activity in Behcet’s Disease
Cai, T., Wang, Q., Zhou, Q., Wang, C., Hou, S., Qi, J., Kijlstra, A., & Yang, P. (2013) · PLoS ONE · doi:10.1371/journal.pone.0059009 · Cited by 41
Decreased interleukin 27 expression is associated with active uveitis in Behçet’s disease
Wang, C., Tian, Y., Ye, Z., Kijlstra, A., Zhou, Y. N., & Yang, P. (2014) · Arthritis Research & Therapy · doi:10.1186/ar4570 · Cited by 40
IL-22-secreting Th22 and IFN-γ-secreting Th17 cells in Behçet's disease
Çetin, E. A., Coşan, F., Çefle, A., & Deniz, G. (2014) · Modern Rheumatology · doi:10.3109/14397595.2013.879414 · Cited by 39
The Yin and Yang of regulatory T cell and therapy progress in autoimmune disease
Qiao, Y.-C., Pan, Y.-H., Wei, L., Tian, F., Chen, Y.-L., Zhang, X., & Zhao, H. (2017) · Autoimmunity Reviews · doi:10.1016/j.autrev.2017.08.001 · Cited by 38
Sönmez, C., Yücel, A. A., Yeşil, T. H., Küçük, H., Sezgin, B., Mercan, R., Yücel, E., & Demirel, G. Y. (2018) · Clinical Rheumatology · doi:10.1007/s10067-018-4049-7 · Cited by 36
S-antigen specific T helper type 1 response is present in Behcet's disease.
Zhao, C., Yang, P., He, H., Lin, X., Li, B., Zhou, H., Huang, X.-K., & Kijlstra, A. (2008) · Europe PMC (PubMed Central) · Cited by 20
Natural killer cells: versatile roles in autoimmune and infectious diseases
Aktas, E., Erten, G., Küçüksezer, U. C., & Deniz, G. (2009) · Expert Review of Clinical Immunology · doi:10.1586/eci.09.27 · Cited by 17
Clemente, A., Crespı́, C., Conejero, A. C., Ferreres, L. P., Más, A. J., Olea, J. L., & Juliá, M. R. (2015) · Human Immunology · doi:10.1016/j.humimm.2015.10.001 · Cited by 13
Metadata
- Authors
- Tong, B., Liu, X., Xiao, J., & Su, G.
- Venue
- Frontiers in Immunology
- Publisher
- Frontiers Media SA
- Published
- 2019-03-29
- Volume
- 10
- Pages
- 665-665
- ISSN
- 1664-3224 (ISSN-L)
- OpenAlex
- W2926902750
- Cited by
- 282
- References
- 91
- FWCI
- 28.40
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.